Ternary Complexes of Flurbiprofen with HP-ß-CD and Ethanolamines Characterization and Transdermal Delivery

REFERENCES

• Angiano-Igea S., Otero-Espinar F. J., Vila-Jato J. L., Blanco-Mendez J. Improvement of clofibrate dissolution by complexation with cyclodextrin. Int. J. Pharm. 1996; 135: 161–166
   Google Scholar
• Antoniadou-Vyza E., Buckton G., Michaleas S. G., Loukas Y., Efentakis M. The formation of an inclusion complex of methocarbamol with hydroxypropyl-ß-cyclodextrin: the effect on chemical stability, solubility and dissolution rate. Int. J. Pharm. 1997; 158: 233–239
   Web of Science ®Google Scholar
• Cheong H.-A., Choi H. K. Enhanced percutaneous absorption of piroxicam via salt formation with ethanolamines. Pharm. Res. 2002; 19: 1372–1377
   Google Scholar
• Duchêne D., Wouessidjewe D. Pharmaceutical uses of cyclodextrins and derivatives. Drug Dev. Ind. Pharm. 1990; 16: 175–182
   Web of Science ®Google Scholar
• Fang L., Numajiri S., Kobayashi D., Ueda H., Nakayama K., Miyamae H., Morimoto Y. Physicochemical and crystallographic characterization of mefenamic acid complexes with alkanolamines. J. Pharm. Sci. 2004; 93: 144–154
   PubMed Web of Science ®Google Scholar
• Faucci M. T., Melani F., Mura P. 1H-NMR and molecular modelling techniques for the investigation of the inclusion complex of econazole with α-cyclodextrin in the presence of malic acid. J. Pharm. Biomed. Anal. 2000; 23: 25–31
   PubMed Web of Science ®Google Scholar
• FDA, Guidance for Industry (1997): Dissolution testing of immediate Release Solid Oral Dosage Forms.
   Google Scholar
• Funk O., Schwabe L., Fromming K. Freeze-dried preparations of ketoprofen and heptakis-(2,6-dimethyl)-β-cyclodextrin. Drug. Dev. Ind. Pharm. 1969; 20: 1957–1969
   Google Scholar
• Gamisans F., Lacoulonche A., Chauvet M., Espina M., García M. L., Egea M. A. Flurbiprofen-loaded nanospheres: analysis of the matrix structure by thermal methods. Int. J. Pharm. 1999; 179: 37–48
   PubMed Web of Science ®Google Scholar
• Granero G., Garnero C., Longhi M. The effect of pH and triethanolamine on sulfisoxale complexation with hydroxypropyl-β-cyclodextrin. Eur. J. Pharm. Sci. 2003; 20(3)285–293
   PubMed Web of Science ®Google Scholar
• Harrison S. M., Barry B. W., Dugard P. H. Effects of freezing on human skin permeability. J. Pharm. Pharmacol. 1984; 36: 261–262
   PubMed Web of Science ®Google Scholar
• Higuchi T., Connors K. Phase solubility techniques. Advances in Analytical Chemistry and Instrumentation, C. Reilly. Wiley/Interscience, New York 1965; 117–212
   Google Scholar
• Knutson K., Krill S. L., Zhang J. Solvent mediated alteration of the stratum corneum. J. Control. Releas. 1990; 11: 93–103
   Web of Science ®Google Scholar
• Li P., Zhao L. Solubilization of flurbiprofen in pH-surfactant solutions. J. Pharm. Sci. 2003; 92(5)951–956
   PubMed Web of Science ®Google Scholar
• Loftsson T., Guomundsdottir H., Sigurjonsdottir J. F., Sigurosson H. H., Sigfusson S. D., Masson M., Stefansson E. Cyclodextrin solubilization of benzodiazepines: formulation of midazolam nasal spray. Int. J. Pharm. 2001; 212: 29–40
   PubMed Web of Science ®Google Scholar
• Loftsson T., Masson M. Cyclodextrins in topical drug formulations: theory and practice. Int. J. pharm. 2001; 225: 15–30
   PubMed Web of Science ®Google Scholar
• Loftsson T., Masson M., Sigurdsson H. H., Magmusson P., Legoffic F. Cyclodextrins as co-enhancers in dermal and transdermal drug delivery. Die Pharmazie 1998; 53: 137–139
   PubMed Web of Science ®Google Scholar
• Lopez R. F. V., Collett J. H., Bentley V. L. B. Influence of cyclodextrin complexation on the in vitro permeation and skin metabolism of dexamethasone. Int. J. Pharm. 2000; 200: 127–132
   PubMed Web of Science ®Google Scholar
• Martindale, The Extra Pharmacopoeia (1989). The Pharmaceutical Press, editors. London, p 18–19.
   Google Scholar
• Nakai Y., Yamamoto K., Terada K., Watanabe D. New methods for preparing cyclodextrin inclusion compounds. I. Heating in a sealed container. Chem. Pharm. Bull. 1987; 35: 4609–4617
   Web of Science ®Google Scholar
• Poul J., West J., Buchanan N., Grahame R. Local action transcutaneous flurbiprofen in the treatment of soft tissue rheumatism. Br. J. Pharmacol. 1993; 32: 1000–1003
   Web of Science ®Google Scholar
• Potts R. O., Guy R. H. A predictive algorithm for skin permeability: the effects of molecular size and hydrogen bond activity. Pharm. Res. 1995; 12: 1628–1633
   PubMed Web of Science ®Google Scholar
• Scalia S., Villani S., Scatturin A., Vandelli M. A., Forni F. Complexation of the sunscreen agent, butylmethoxydibenzoylmethane, with hydroxypropyl-ß-cyclodextrin. Int. J. Pharm. 1998; 175: 205–213
   Web of Science ®Google Scholar
• Schaefer U., Loth H. An ex vivo model for the study of drug penetration into human skin. Pharm. Res. 1996; 13(Suppl)366
   Google Scholar
• Shah V. P., Tsong Y., Sathe P., Williams R. L. Dissolution profile comparison using similarity factor, f2. Dissolution Technol. 1999; 6: 15
   Google Scholar
• Sigurdardóttir A. M., Loftsson T. The effect of polyvinylpirrolidone on cyclodextrin complexation of hydrocortisone and its diffusion through hairless mouse skin. Int. J. Pharm 1995; 126: 73–78
   Google Scholar
• Szejtli J. Medicinal applications of cyclodextrins. Med. Res. Rev. 1994; 14: 353–386
   PubMed Web of Science ®Google Scholar
• Szente L., Szejtli J. Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development. Adv. Drug Deliv. Rev. 1999; 36: 17–28
   PubMed Web of Science ®Google Scholar
• Tavornvipas S., Hirayama F., Arima H., Uekama K., Ishiguro T., Oka M., Hamayasu K., Hashimoto H. 6-O-α-(4-O-α-D-glucuronyl) -D-glucosyl-ß-cyclodextrin: solubilizing ability and some cellular effects. Int. J. Pharm. 2002; 249: 199–209
   PubMedGoogle Scholar
• Uekma K., Adachi H., Irie T., Yano T., Saita M., Noda K. Improved transdermal delivery of prostaglandin E1 through hairless mouse skin: combined use of carboxymethyl-ethyl-ß-cyclodextrin and penetration enhancers. J. Pharm. Pharmacol 1992; 44: 119–121
   PubMed Web of Science ®Google Scholar
• Williams A. C., Shatri S. R. S., Barry B. W. Transdermal Permeation Modulation by cyclodextrins: a mechanistic study. Pharm. Dev. Technol. 1998; 3: 283–296
   PubMedGoogle Scholar
• Williams R. O., Liu J. Influence of formulation technique for hydroxypropyl-ß-cyclodextrin on the stability of aspirin in HFA 134a. Eur. Pharm. Biopharm. 1999; 47: 145–152
   PubMed Web of Science ®Google Scholar